Market Research Report

Global Clinical Trial Supply & Logistics Market Report By Service (Logistics & Distribution, Storage & Retention, Packaging, Labeling, And Blinding, Manufacturing, Comparator Sourcing, Other Services (Solutions, Ancillary Supply)), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-user (Pharmaceuticals, Biologicals, Medical Device), By Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS And Mental Disorders, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11220639
March 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Clinical Trial Supply & Logistics Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Clinical trial supply and logistics refer to the management and delivery of investigational drug products, medical devices, and other supplies that are used in clinical trials. It involves the planning, sourcing, packaging, labelling, storage, distribution, and delivery of these products to clinical trial sites around the world. Clinical trial supply and logistics also involve the management of inventory levels, the tracking of shipments, and the provision of support services to clinical trial sites, such as training, technical support, and emergency resupply. 

Market Dynamics 

With the growing need for new and innovative therapies, there is an increasing demand for clinical trials. This is driving the growth of the clinical trial supply and logistics market, as more investigational products need to be managed and delivered to trial sites. Clinical trials are increasingly being conducted in emerging markets, such as Asia, Latin America, and Eastern Europe, which is driving the growth of the clinical trial supply and logistics market. This requires specialized expertise in navigating complex regulatory environments, managing international logistics, and ensuring compliance with local regulations. Clinical trial supply chains are becoming increasingly complex, with multiple vendors and suppliers involved in the production and delivery of investigational products and require specialized expertise to ensure the efficient delivery of products to clinical trial sites. The clinical trial supply and logistics market is highly regulated, with strict quality standards and regulatory requirements. This requires specialized expertise in regulatory affairs to ensure compliance with local and international regulations. The development of new technologies, such as blockchain, AI, and IoT, is driving the growth of the clinical trial supply and logistics market. These technologies can improve supply chain visibility, enhance data security, and optimize logistics operations. As clinical trials become more complex, pharmaceutical and biotech companies are increasingly outsourcing clinical trial services, including supply and logistics management, to specialized providers. This is driving the growth of the clinical trial supply and logistics market

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical trial supply & logistics. The growth and trends of clinical trial supply & logistics industry provide a holistic approach to this study. 

Market Segmentation

This section of the clinical trial supply & logistics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Service
  • Logistics & Distribution
  • Storage & Retention
  • Packaging, Labeling, And Blinding
  • Manufacturing
  • Comparator Sourcing
  • Other Services (Solutions, Ancillary Supply)

By Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End-User
  • Pharmaceuticals
  • Biologicals
  • Medical Device

By Area
  • Oncology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • CNS And Mental Disorders
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Supply & Logistics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Clinical Trial Supply & Logistics Market Share by Region (Representative Graph)

Global Clinical Trial Supply & Logistics Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the clinical trial supply & logistics market include Thermo Fisher Scientific (Patheon), Catalent Inc., Parexel, Almac Group, Marken, Piramal Pharma Solutions, UDG Healthcare, DHL, FedEx, Movianto, Packaging Coordinators Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . CLINICAL TRIAL SUPPLY & LOGISTICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Service
           3.7.2 Market Attractiveness Analysis By Phase
           3.7.3 Market Attractiveness Analysis By End-user
           3.7.4 Market Attractiveness Analysis By Area
           3.7.5 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET ANALYSIS BY SERVICE
       6.1 Overview by Service
       6.2 Historical and Forecast Data
       6.3 Analysis by Service
       6.4 Logistics & Distribution Historic and Forecast Sales by Regions
       6.5 Storage & Retention Historic and Forecast Sales by Regions
       6.6 Packaging, Labeling, And Blinding Historic and Forecast Sales by Regions
       6.7 Manufacturing Historic and Forecast Sales by Regions
       6.8 Comparator Sourcing Historic and Forecast Sales by Regions
       6.9 Other Services (Solutions, Ancillary Supply) Historic and Forecast Sales by Regions
 
7 . GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET ANALYSIS BY PHASE
       7.1 Overview by Phase
       7.2 Historical and Forecast Data
       7.3 Analysis by Phase
       7.4 Phase I Historic and Forecast Sales by Regions
       7.5 Phase II Historic and Forecast Sales by Regions
       7.6 Phase III Historic and Forecast Sales by Regions
       7.7 Phase IV Historic and Forecast Sales by Regions
 
8 . GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET ANALYSIS BY END-USER
       8.1 Overview by End-user
       8.2 Historical and Forecast Data
       8.3 Analysis by End-user
       8.4 Pharmaceuticals Historic and Forecast Sales by Regions
       8.5 Biologicals Historic and Forecast Sales by Regions
       8.6 Medical Device Historic and Forecast Sales by Regions
 
9 . GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET ANALYSIS BY AREA
       9.1 Overview by Area
       9.2 Historical and Forecast Data
       9.3 Analysis by Area
       9.4 Oncology Historic and Forecast Sales by Regions
       9.5 Cardiovascular Diseases Historic and Forecast Sales by Regions
       9.6 Respiratory Diseases Historic and Forecast Sales by Regions
       9.7 CNS And Mental Disorders Historic and Forecast Sales by Regions
       9.8 Others Historic and Forecast Sales by Regions
 
10 . GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America Sales Analysis
           10.3.1. Overview, Historic and Forecast Sales Analysis
           10.3.2. North America By Segment Sales Analysis
           10.3.3. North America By Country Sales Analysis
           10.3.4. United State Sales Analysis
           10.3.5. Canada Sales Analysis
           10.3.6. Mexico Sales Analysis
       10.4. Europe Sales Analysis
           10.4.1. Overview, Historic and Forecast Sales Analysis
           10.4.2. Europe by Segment Sales Analysis
           10.4.3. Europe by Country Sales Analysis
           10.4.4. United Kingdom Sales Analysis
           10.4.5. France Sales Analysis
           10.4.6. Germany Sales Analysis
           10.4.7. Italy Sales Analysis
           10.4.8. Russia Sales Analysis
           10.4.9. Rest Of Europe Sales Analysis
       10.5. Asia Pacific Sales Analysis
           10.5.1. Overview, Historic and Forecast Sales Analysis
           10.5.2. Asia Pacific by Segment Sales Analysis
           10.5.3. Asia Pacific by Country Sales Analysis
           10.5.4. China Sales Analysis
           10.5.5. India Sales Analysis
           10.5.6. Japan Sales Analysis
           10.5.7. South Korea Sales Analysis
           10.5.8. Australia Sales Analysis
           10.5.9. Rest Of Asia Pacific Sales Analysis
       10.6. Latin America Sales Analysis
           10.6.1. Overview, Historic and Forecast Sales Analysis
           10.6.2. Latin America by Segment Sales Analysis
           10.6.3. Latin America by Country Sales Analysis
           10.6.4. Brazil Sales Analysis
           10.6.5. Argentina Sales Analysis
           10.6.6. Peru Sales Analysis
           10.6.7. Chile Sales Analysis
           10.6.8. Rest of Latin America Sales Analysis
       10.7. Middle East & Africa Sales Analysis
           10.7.1. Overview, Historic and Forecast Sales Analysis
           10.7.2. Middle East & Africa by Segment Sales Analysis
           10.7.3. Middle East & Africa by Country Sales Analysis
           10.7.4. Saudi Arabia Sales Analysis
           10.7.5. UAE Sales Analysis
           10.7.6. Israel Sales Analysis
           10.7.7. South Africa Sales Analysis
           10.7.8. Rest Of Middle East And Africa Sales Analysis
 
11 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL SUPPLY & LOGISTICS COMPANIES
       11.1. Clinical Trial Supply & Logistics Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments
 
12 . COMPANY PROFILES OF CLINICAL TRIAL SUPPLY & LOGISTICS INDUSTRY
       12.1. Top Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Thermo Fisher Scientific (Patheon)
           12.3.1. Company Overview
           12.3.2. Company Revenue
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. Catalent Inc.
           12.4.1. Company Overview
           12.4.2. Company Revenue
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. Parexel
           12.5.1. Company Overview
           12.5.2. Company Revenue
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Almac Group
           12.6.1. Company Overview
           12.6.2. Company Revenue
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. Marken
           12.7.1. Company Overview
           12.7.2. Company Revenue
           12.7.3. Products
           12.7.4. Recent Developments
       12.8. Piramal Pharma Solutions
           12.8.1. Company Overview
           12.8.2. Company Revenue
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. UDG Healthcare
           12.9.1. Company Overview
           12.9.2. Company Revenue
           12.9.3. Products
           12.9.4. Recent Developments
       12.10. DHL
           12.10.1. Company Overview
           12.10.2. Company Revenue
           12.10.3. Products
           12.10.4. Recent Developments
       12.11. FedEx
           12.11.1. Company Overview
           12.11.2. Company Revenue
           12.11.3. Products
           12.11.4. Recent Developments
       12.12. Movianto
           12.12.1. Company Overview
           12.12.2. Company Revenue
           12.12.3. Products
           12.12.4. Recent Developments
       12.13. Packaging Coordinators Inc.
           12.13.1. Company Overview
           12.13.2. Company Revenue
           12.13.3. Products
           12.13.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Service (USD MN)
  •  Logistics & Distribution Market Sales by Geography (USD MN)
  •  Storage & Retention Market Sales by Geography (USD MN)
  •  Packaging, Labeling, And Blinding Market Sales by Geography (USD MN)
  •  Manufacturing Market Sales by Geography (USD MN)
  •  Comparator Sourcing Market Sales by Geography (USD MN)
  •  Other Services (Solutions, Ancillary Supply) Market Sales by Geography (USD MN)
  •  Analysis Market by Phase (USD MN)
  •  Phase I Market Sales by Geography (USD MN)
  •  Phase II Market Sales by Geography (USD MN)
  •  Phase III Market Sales by Geography (USD MN)
  •  Phase IV Market Sales by Geography (USD MN)
  •  Analysis by End-user (USD MN)
  •  Pharmaceuticals Market Sales by Geography (USD MN)
  •  Biologicals Market Sales by Geography (USD MN)
  •  Medical Device Market Sales by Geography (USD MN)
  •  Analysis by Area (USD MN)
  •  Oncology Market Sales by Geography (USD MN)
  •  Cardiovascular Diseases Market Sales by Geography (USD MN)
  •  Respiratory Diseases Market Sales by Geography (USD MN)
  •  CNS And Mental Disorders Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Clinical Trial Supply & Logistics Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Clinical Trial Supply & Logistics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Clinical Trial Supply & Logistics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Service
  •  Market Attractiveness Analysis by Phase
  •  Market Attractiveness Analysis by End-user
  •  Market Attractiveness Analysis by Area
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Service (USD MN)
  •  Logistics & Distribution Market Sales by Geography (USD MN)
  •  Storage & Retention Market Sales by Geography (USD MN)
  •  Packaging, Labeling, And Blinding Market Sales by Geography (USD MN)
  •  Manufacturing Market Sales by Geography (USD MN)
  •  Comparator Sourcing Market Sales by Geography (USD MN)
  •  Other Services (Solutions, Ancillary Supply) Market Sales by Geography (USD MN)
  •  Global Market Analysis by Phase (USD MN)
  •  Phase I Market Sales by Geography (USD MN)
  •  Phase II Market Sales by Geography (USD MN)
  •  Phase III Market Sales by Geography (USD MN)
  •  Phase IV Market Sales by Geography (USD MN)
  •  Global Market Analysis by End-user (USD MN)
  •  Pharmaceuticals Market Sales by Geography (USD MN)
  •  Biologicals Market Sales by Geography (USD MN)
  •  Medical Device Market Sales by Geography (USD MN)
  •  Global Market Analysis by Area (USD MN)
  •  Oncology Market Sales by Geography (USD MN)
  •  Cardiovascular Diseases Market Sales by Geography (USD MN)
  •  Respiratory Diseases Market Sales by Geography (USD MN)
  •  CNS And Mental Disorders Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials